Sigh, to be honest, I suddenly noticed that Changfeng Pharmaceutical (2652.HK) has been quite active these past two days, rising nearly 4.5%. I thought it had only been listed for just over a month—could the new stock hype still be lingering? The trading volume looks decent, but the turnover rate is only 0.13%, which feels like a symbolic little shake. Ah, this... Could it be another short-term play?

I saw news about some joint R&D for a new COVID drug, and I’m a bit skeptical. Is this theme still playable now? Aren’t people chasing medical aesthetics and innovative drugs more aggressively these days? COVID is so 2022, but hey, capital is just weird—always loves reheating leftovers.

Also, the community buzz is kinda funny. Everyone’s chattering away, even though the market cap is already over 10 billion. It feels like a bunch of newbies collectively surfing the wave, lol. People are just purely watching the secondary market performance. Honestly, pharma stocks have been like this lately—sudden rebounds. HK pharma stocks change every few days; capital just flinches and jumps to another stock—whack-a-mole isn’t even this fast. 🤷‍♂️

I’m not sure how long this hype can last. Changfeng’s business is still unproven, they say. For short-term plays, don’t bet too hard on luck—who knows if the next wave will bring an even hotter trend?